Search results for "EFT"

showing 10 items of 904 documents

Fully robotic left hepatectomy for malignant tumor: technique and initial results

2018

Robotic liver surgery has been considered as a unique opportunity to overcome the traditional limitations of laparoscopy; thus, it can potentially extend the indications of minimally invasive liver surgery. From April 2015 to May 2017, 35 patients underwent fully robotic left hepatectomy. The mean operative time was 315 min (200-445 min) and the mean estimated blood loss was 245 ml (125-628 ml). Pringle maneuver was required in six cases. Cancer was the indication for surgery in all patients (14 liver metastases, 18 hepatocellular carcinomas and 3 cholangiocarcinomas). There were one to four lesions in a patient and the mean lesion size was 39.2 mm (15-85 mm). The average length of hospital…

Adultmedicine.medical_specialtyCarcinoma Hepatocellularmedicine.medical_treatmentOperative TimeBlood Loss Surgical030230 surgeryCholangiocarcinomaLesion03 medical and health sciences0302 clinical medicineRobotic Surgical ProceduresBlood lossMinimally invasive surgerymedicineHepatectomyHumansRobotic left hepatectomyLaparoscopyAgedLiver resectionmedicine.diagnostic_testbusiness.industryMortality rateLiver NeoplasmsMargins of ExcisionCancerPerioperativeLength of StayMiddle Agedmedicine.diseaseRobotic liver resectionSurgerySettore MED/18 - Chirurgia GeneraleTreatment OutcomeLiver030220 oncology & carcinogenesisOperative timeFemaleSurgeryHepatectomymedicine.symptombusinessUpdates in Surgery
researchProduct

Acoustic Airway Profiles in Unilateral Cleft Palate Patients

1999

Objective: This study investigates the nasal airway in unilateral cleft palate patients by means of a noninvasive, objective diagnostic method that provides topographic information about the airway profile. Design: A consecutive sample of patients was measured. Setting: Cleft palate rehabilitation center of the University of Mainz, Germany. Patients: Forty-nine subjects were investigated: 34 full-grown patients with complete unilateral cleft lip and palate and 15 controls with subjective normal nasal patency. Intervention: A transnasal series of three acoustic measurements of nasal volume was performed per nostril; measurements were taken both before and after decongestion with 0.3 mg xylom…

Adultmedicine.medical_specialtyDiagnostic methodsAdolescentNostrilBiophysicsNoseStatistics NonparametricUnilateral cleft palateNasal airwayXylometazolineCONSECUTIVE SAMPLE03 medical and health sciences0302 clinical medicineAcoustic Impedance TestsmedicineHumans030223 otorhinolaryngologybusiness.industryImidazolesAcoustics030206 dentistrySurgeryCleft PalateNasal Decongestantsmedicine.anatomical_structureOtorhinolaryngologyNasal CavityNasal ObstructionOral SurgeryAirwaybusinessmedicine.drugThe Cleft Palate-Craniofacial Journal
researchProduct

Migraine and handedness.

2020

Migraine is a typically unilateral disorder in adulthood; however, the reasons for painful lateralization have been little investigated. The possible influence of manual dominance was suggested. We aimed to investigate the localization of pain in migraine attacks in right-handed and left-handed subjects. The retrospective study collected 546 patients with migraine aged between 16 and 65 years, reporting the manual dominance to the Edinburgh test. We included 466 right-handed and 80 left-handed subjects with migraine. We registered 4215 unilateral painful attacks. The right-handers had 3412 unilateral episodes; 62.8% of the attacks were characterized by pain on the right side and 37.2% by pa…

Adultmedicine.medical_specialtyNeurologyAdolescentMigraine DisordersPainDermatologyManual dominanceAudiologyLateralization of brain functionFunctional Laterality03 medical and health sciencesYoung AdultRight-handers0302 clinical medicineLeft-handersmedicineHumans030212 general & internal medicineUnilateral painHandednessMigraineNeuroradiologyAgedRetrospective Studiesbusiness.industryRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseHandPsychiatry and Mental healthManual dominanceMigraineNeurology (clinical)Neurosurgerybusiness030217 neurology & neurosurgeryPsychomotor PerformanceNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Cardiac manifestations of Anderson-Fabry disease in heterozygous females.

2002

AbstractObjectivesWe sought to define the prevalence of cardiac involvement in female patients with Anderson–Fabry disease (AFD).BackgroundAnderson–Fabry disease is a rare inborn X-linked lysosomal storage disorder. Globotriaosylceramide (Gb3), the major substrate of the deficient α-galactosidase A enzyme, accumulates progressively in vulnerable cells, including the cardiovascular system. It has been believed that heterozygous females have less cardiac involvement than hemizygous males with AFD.MethodsWe performed two-dimensional echocardiographic examinations of female patients heterozygous for AFD.ResultsSince 1997, a total of 55 female patients (mean age, 39.6 years; range, 6.1 to 70.8 y…

Adultmedicine.medical_specialtyPediatricsHeterozygoteendocrine system diseasesHeart diseaseAdolescentSystoleHeart Valve DiseasesDiseaseVentricular Dysfunction LeftFemale patientotorhinolaryngologic diseasesmedicinePrevalenceHumanscardiovascular diseasesProspective StudiesSystoleProspective cohort studyChildneoplasmsAgedVascular diseasebusiness.industryAge FactorsMiddle Agedmedicine.diseaseFabry diseasehumanitiesSurgeryPedigreeAnderson-Fabry DiseaseEchocardiographyFabry Diseaselipids (amino acids peptides and proteins)FemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicinebusinessJournal of the American College of Cardiology
researchProduct

Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumab.

2018

Abstract Background Cardiac toxicity with a decrease of the left ventricular ejection fraction (LVEF) is the main side effect induced by trastuzumab. This study reports the fluctuation of LVEF over the 12 months of adjuvant trastuzumab in PHARE trial (NCT00381901). Methods LVEF assessment was performed every 3 months while patients received trastuzumab and after completion of treatment over the first 2 years and then every 6 months afterwards. The fluctuations of LVEF over time were described and a logistic regression model was performed investigating associated factors to LVEF perfect recovery at baseline value. Results A total of 1631 patients who received 12 months of trastuzumab from PH…

Adultmedicine.medical_specialtySide effectReceptor ErbB-2medicine.medical_treatmentBreast Neoplasms030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicineBreast cancerAntineoplastic Agents ImmunologicalTrastuzumabInternal medicinemedicineHumansIn patientcardiovascular diseasesCardiotoxicityEjection fractionbusiness.industryGeneral MedicineMiddle AgedTrastuzumabmedicine.diseaseCardiotoxicityStandard errorChemotherapy AdjuvantEchocardiography030220 oncology & carcinogenesiscardiovascular systemCardiologySurgeryFemalebusinessAdjuvantcirculatory and respiratory physiologymedicine.drugFollow-Up StudiesBreast (Edinburgh, Scotland)
researchProduct

Chimney and periscope grafts to facilitate endovascular treatment of aortic transection in a patient with aberrant right subclavian artery

2014

Purpose: To report the use of parallel grafts to extend the proximal landing zone for stentgraft repair of aortic transection involving an aberrant right subclavian artery (ARSA). Case Report: A 28-year-old patient was referred for treatment of traumatic aortic transection with contained rupture at the level of an ARSA. Immediate thoracic endovascular aortic repair (TEVAR) was planned because of hemodynamic instability. To achieve rapid sealing and maintain perfusion to both subclavian arteries, a chimney stent to the left subclavian artery (LSA) and a periscope stent-graft to the ARSA were deployed successfully. After surgical repair of all fractures, the patient was discharged 1 month aft…

Adultmedicine.medical_specialtyTime FactorsAortic RuptureCardiovascular AbnormalitiesSubclavian ArteryHemodynamics610 Medicine & healthProsthesis DesignAortographySettore MED/22 - Chirurgia Vascolare2705 Cardiology and Cardiovascular MedicineBlood Vessel Prosthesis ImplantationBlood vessel prosthesisX ray computedmedicine.arterymedicineHumansThoracic aorta2741 Radiology Nuclear Medicine and ImagingRadiology Nuclear Medicine and imagingcardiovascular diseasesEndovascular treatmentAortabusiness.industryEndovascular ProceduresHemodynamicsAberrant right subclavian arteryVascular System InjuriesAneurysmBlood Vessel ProsthesisSurgery10020 Clinic for Cardiac Surgery2746 SurgeryTreatment Outcomesurgical procedures operativeRegional Blood FlowLanding zonecardiovascular systemStentsSurgeryAneurysm surgeryRadiologyDeglutition DisordersTomography X-Ray ComputedCardiology and Cardiovascular Medicinebusinessthoracic aorta aortic transection trauma thoracic endovascular aortic repair aberrant right subclavian artery left subclavian artery stent-graft parallel graft chimney graft periscope graft landing zone
researchProduct

Electrocardiography plus limited echocardiography in young, newly identified, hypertensives: some considerations.

2010

Adultmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryCost-Benefit AnalysisAge FactorsElectrocardiography echocardiography left ventricular hypertrophy hypertensionGuidelines as TopicMiddle AgedElectrocardiographyEchocardiographyInternal medicineHypertensionInsurance Health ReimbursementInternal MedicineCardiologymedicineHumansHypertrophy Left VentricularbusinessElectrocardiographyAmerican journal of hypertension
researchProduct

Ceftolozane Pharmacokinetics in a Septic Critically Ill Patient under Different Extracorporeal Replacement Therapies

2019

Ceftolozane-tazobactam (C/T), a novel fifth-generation cephalosporin/β-lactamase inhibitor combination active against multidrug-resistant (MDR) Pseudomonas aeruginosa, is currently approved by the U.S. Food and Drug Administration (FDA) to treat complicated intra-abdominal and urinary tract

Adultmedicine.medical_specialtymedicine.drug_classCritical IllnessUrinary systemCephalosporinHemodiafiltrationMicrobial Sensitivity TestsOff-label usemedicine.disease_causeExtracorporealPharmacokineticspolycyclic compoundsmedicineHumansPseudomonas InfectionsPharmacology (medical)Intensive care medicineLetter to the EditorPharmacologyCritically illbusiness.industryPseudomonas aeruginosaPrecursor Cell Lymphoblastic Leukemia-Lymphomabacterial infections and mycosesAnti-Bacterial AgentsCephalosporinsInfectious DiseasesPseudomonas aeruginosaFemaleCeftolozanebusinessAntimicrobial Agents and Chemotherapy
researchProduct

Factors Affecting Early Mortality and 1-Year Outcomes in Young Women With ST-Segment-Elevation Myocardial Infarction Aged Less Than or Equal to 45 Ye…

2018

Given that up to 2% of patients with myocardial infarction (MI) are young women, the purpose of this study was to evaluate factors affecting outcomes in young women with ST-segment-elevation myocardial infarction (STEMI) aged less than or equal to 45 years. We evaluated 796 women with STEMI aged less than or equal to 45 years between 2007 and 2014, and mortality was 4.0%. Death occurred more often in women with prehospital sudden cardiac arrest, and severe symptoms of heart failure; less commonly, the women were subjected to percutaneous coronary intervention (PCI), with a higher rate of incomplete revascularization. Beta blockers (BB) and angiotensin converting enzyme inhibitors were frequ…

Adultmedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRisk FactorsInternal medicineMedicineHumans030212 general & internal medicineMyocardial infarctionEjection fractionbusiness.industryMortality rateHazard ratioAge FactorsPercutaneous coronary interventionStroke VolumeGeneral MedicineMiddle Agedmedicine.diseaseBlood pressureTreatment OutcomeHeart failureConventional PCICardiologyST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessCurrent problems in cardiology
researchProduct

Laparoscopic aortic lymphadenectomy in left-sided inferior vena cava

2020

Transposition of the inferior vena cava (IVC), also known as left-sided IVC (LS-IVC), is a rare congenital variant which results from regression of the right supracardinal vein and persistence of the left supracardinal vein in embryonic development.[1 2][1] LS-IVC occurs in 0.2–0.5% of the general

Adultoperativemedicine.medical_specialtycervical cancermedicine.medical_treatmentVena Cava Inferiorgynecologic surgical proceduresLeft sidedInferior vena cavaGynecologic surgical proceduresLeft supracardinal vein03 medical and health sciences0302 clinical medicinelaparoscopegynecologic surgical proceduresurgical procedures operativeHumansMedicineadenocarcinoma030219 obstetrics & reproductive medicinebusiness.industryObstetrics and Gynecologysurgical proceduresSurgerylaparoscopesSettore MED/40 - GINECOLOGIA E OSTETRICIAOncologymedicine.vein030220 oncology & carcinogenesiscardiovascular systemLymph Node ExcisionLaparoscopyFemaleLymphadenectomybusinessRight supracardinal veinInternational Journal of Gynecologic Cancer
researchProduct